Safety of second generation antihistamines

Area of Science:

• Pharmacology
• Clinical Trials
• Drug Safety

Background:

• First-generation antihistamines cause sedation, impairing daily activities and cognitive function.
• Second-generation antihistamines offer a less sedating alternative.
• Loratadine, cetirizine, and fexofenadine are common second-generation antihistamines.

Purpose of the Study:

• To evaluate the central nervous system effects of loratadine, cetirizine, and fexofenadine.
• To compare the safety and efficacy of these second-generation antihistamines.
• To assess potential performance impairment and cognitive effects.

Main Methods:

• Review of clinical trials and psychomotor testing data.
• Comparison of loratadine, cetirizine, and fexofenadine against placebo.
• Evaluation of safety data in various patient populations.

Main Results:

• Loratadine and fexofenadine showed no performance impairment at recommended doses.
• Cetirizine demonstrated mild cognitive and performance impairment in some studies.
• Fexofenadine remained non-sedating even at high doses.
• All three drugs exhibited excellent safety profiles, including cardiovascular safety.

Conclusions:

• Loratadine and fexofenadine are suitable non-sedating options for allergy relief.
• Cetirizine may cause mild impairment, requiring consideration for tasks needing high alertness.
• These second-generation antihistamines are safe for pediatric and elderly populations.